Pharmafile - Research and Development News
European Commission has moved to expand the existing approved indication for Mundipharma’s Invokana (canagliflozin), making it the first sodium ...
Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part of their BNT162 RNA-based...
Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s drug remdesivir, which is one of the...
EUSA Pharma has announced that the FDA has given the go-ahead for randomized, double-blind, placebo-controlled Phase 3 clinical trial to evaluate its...
The city of Leicester has been locked down after seeing a surge in COVID-19 cases. This surge is visible in Pillar 2 data now released, but not the...
The FDA has moved to approve Bavencio, developed by Pfizer and EMD Serono, the biopharma arm of Merck KGaA, as a maintenance therapy for the...
Takeda has linked up with Carmine Therapeutics in a new partnership to discover, develop and bring to market new non-viral gene therapies for two...
COVID-19 vaccines dominate this week’s news cycle, with Vaxart announcing the selection of its lead candidate for COVID-19 by Operation Warp Speed,...
The US has bought most of the world’s stock of the drug remdesivir which is one of the only drugs proven to treat COVID-19.
The FDA announced that any COVID-19 vaccine that gets approval must show that it is at least 50% more effective than a placebo in treating the virus.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
